TENET HEALTHCARE CORP - Common Stock (THC)

Historical Holders from Q1 2014 to Q1 2025

Symbol
THC on NYSE
CUSIP
88033G407
Type / Class
Equity / Common Stock
Shares outstanding
95.4M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
90.8M
Holdings value
$11.5B
% of all portfolios
0.013%
Grand Portfolio weight change
+0.001%
Number of holders
573
Number of buys
260
Number of sells
-318
Average Value change %
0%
Average buys %
+0.002%
Average sells %
-0.006%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of TENET HEALTHCARE CORP - Common Stock (THC)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 8.8% $1.13B 8.39M BlackRock, Inc. Mar 31, 2025

Institutional Holders of TENET HEALTHCARE CORP - Common Stock (THC)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 1.46M $196M +$20.8M $134.50 65
2024 Q4 90.8M $11.5B +$276M $126.23 573
2024 Q3 87.3M $14.5B -$597M $166.20 602
2024 Q2 92.1M $12.2B +$3.6M $133.03 531
2024 Q1 92.1M $9.68B -$269M $105.11 456
2023 Q4 95M $7.18B -$3.13M $75.57 415
2023 Q3 94M $6.19B -$66.3M $65.89 400
2023 Q2 93.6M $7.62B -$289M $81.38 405
2023 Q1 99.2M $5.89B -$262M $59.42 354
2022 Q4 103M $5.03B -$178M $48.79 344
2022 Q3 99.5M $5.13B +$56.8M $51.58 338
2022 Q2 99.2M $5.21B -$69.8M $52.56 342
2022 Q1 99.2M $8.53B +$253M $85.96 383
2021 Q4 102M $8.3B +$118M $81.69 358
2021 Q3 101M $6.69B +$40.6M $66.44 323
2021 Q2 99.2M $6.65B +$208M $66.99 311
2021 Q1 97M $5.04B -$71.2M $52.00 302
2020 Q4 98.9M $3.95B -$67.9M $39.93 260
2020 Q3 101M $2.47B +$1.53M $24.51 229
2020 Q2 102M $1.85B +$418K $18.11 222
2020 Q1 103M $1.49B -$56.7M $14.40 231
2019 Q4 103M $3.93B -$215M $38.03 252
2019 Q3 110M $2.43B +$96.6M $22.12 230
2019 Q2 106M $2.18B +$60.7M $20.66 230
2019 Q1 103M $2.97B +$14.1M $28.84 246
2018 Q4 102M $1.74B -$141M $17.14 247
2018 Q3 109M $3.1B +$64.2M $28.46 247
2018 Q2 106M $3.57B -$124M $33.57 240
2018 Q1 111M $2.69B -$104M $24.25 221
2017 Q4 119M $1.81B -$113M $15.16 216
2017 Q3 125M $2.05B +$133M $16.43 221
2017 Q2 117M $2.26B +$89.4M $19.34 228
2017 Q1 112M $1.98B +$464M $17.71 234
2016 Q4 102M $1.51B +$4.84M $14.84 242
2016 Q3 98.1M $2.22B -$49.6M $22.66 248
2016 Q2 99.4M $2.75B -$46.4M $27.64 247
2016 Q1 101M $2.92B -$47.4M $28.93 257
2015 Q4 103M $3.11B -$23.7M $30.30 265
2015 Q3 100M $3.71B +$41.2M $36.92 301
2015 Q2 96.6M $5.59B +$28.2M $57.88 324
2015 Q1 98.2M $4.86B +$154M $49.51 303
2014 Q4 95M $4.81B -$87.3M $50.67 312
2014 Q3 95.3M $5.66B -$43M $59.39 302
2014 Q2 97.1M $4.56B +$15.5M $46.94 283
2014 Q1 97.9M $4.19B +$227M $42.81 280